Contrast induced nephropathy overview: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Contrast induced nephropathy}} | {{Contrast induced nephropathy}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{MM}} | ||
==Overview== | ==Overview== |
Revision as of 15:25, 6 September 2013
Contrast Induced Nephropathy Microchapters |
Differentiating Contrast induced nephropathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Contrast induced nephropathy overview On the Web |
American Roentgen Ray Society Images of Contrast induced nephropathy overview |
Directions to Hospitals Treating Contrast induced nephropathy |
Risk calculators and risk factors for Contrast induced nephropathy overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Contrast media are widely used in diagnostic and interventional procedures with rising incidence of iatrogenic renal function impairment caused by the exposure to contrast media, a condition known as Contrast-induced nephropathy(CIN). Contrast-induced nephropathy is defined as either a greater than 25% increase of serum creatinine or an absolute increase in serum creatinine of 0.5 mg/dL that occur soon after intravenous contrast administration.[1] It is generally a reversible form of acute kidney injury.
References
- ↑ Barrett BJ, Parfrey PS (2006). "Clinical practice. Preventing nephropathy induced by contrast medium". N. Engl. J. Med. 354 (4): 379–86. doi:10.1056/NEJMcp050801. PMID 16436769.